Literature DB >> 24202404

CD49d expression identifies a chronic-lymphocytic leukemia subset with high levels of mobilized circulating CD34(+) hemopoietic progenitors cells.

F M Rossi1, A Zucchetto1, E Tissino1, M Dal Bo1, R Bomben1, C Caldana1, F Pozzo1, G Del Poeta2, D Rossi3, G Gaidano3, V Gattei1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24202404     DOI： 10.1038/leu.2013.331

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  15 in total

1.  The CD49d/CD29 complex is physically and functionally associated with CD38 in B-cell chronic lymphocytic leukemia cells.

Authors:  A Zucchetto; T Vaisitti; D Benedetti; E Tissino; V Bertagnolo; D Rossi; R Bomben; M Dal Bo; M I Del Principe; A Gorgone; G Pozzato; G Gaidano; G Del Poeta; F Malavasi; S Deaglio; V Gattei
Journal:  Leukemia       Date:  2012-01-06       Impact factor: 11.528

2.  Signature of B-CLL with different prognosis by Shrunken centroids of surface antigen expression profiling.

Authors:  Antonella Zucchetto; Paolo Sonego; Massimo Degan; Riccardo Bomben; Michele Dal Bo; Stefania Russo; Vincenza Attadia; Maurizio Rupolo; Francesco Buccisano; Maria Ilaria Del Principe; Giovanni Del Poeta; Carlo Pucillo; Alfonso Colombatti; Renato Campanini; Valter Gattei
Journal:  J Cell Physiol       Date:  2005-07       Impact factor: 6.384

3.  Hematopoietic progenitor cells (HPC) from mobilized peripheral blood display enhanced migration and marrow homing compared to steady-state bone marrow HPC.

Authors:  Halvard Bonig; Gregory V Priestley; Vivian Oehler; Thalia Papayannopoulou
Journal:  Exp Hematol       Date:  2007-02       Impact factor: 3.084

4.  Clinical significance of c.7544-7545 delCT NOTCH1 mutation in chronic lymphocytic leukaemia.

Authors:  Giovanni Del Poeta; Michele Dal Bo; Maria Ilaria Del Principe; Federico Pozzo; Francesca Maria Rossi; Antonella Zucchetto; Riccardo Bomben; Massimo Degan; Silvia Rasi; Davide Rossi; Pietro Bulian; Gianluca Gaidano; Sergio Amadori; Valter Gattei
Journal:  Br J Haematol       Date:  2012-11-20       Impact factor: 6.998

5.  Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.

Authors:  R N Damle; T Wasil; F Fais; F Ghiotto; A Valetto; S L Allen; A Buchbinder; D Budman; K Dittmar; J Kolitz; S M Lichtman; P Schulman; V P Vinciguerra; K R Rai; M Ferrarini; N Chiorazzi
Journal:  Blood       Date:  1999-09-15       Impact factor: 22.113

6.  Neoplastic circulating endothelial cells in multiple myeloma with 13q14 deletion.

Authors:  Gian Matteo Rigolin; Chiara Fraulini; Maria Ciccone; Endri Mauro; Anna Maria Bugli; Cristiano De Angeli; Massimo Negrini; Antonio Cuneo; Gianluigi Castoldi
Journal:  Blood       Date:  2005-11-29       Impact factor: 22.113

7.  Circulating endothelial cells in patients with chronic lymphocytic leukemia: clinical-prognostic and biologic significance.

Authors:  Gian Matteo Rigolin; Rossana Maffei; Lara Rizzotto; Maria Ciccone; Olga Sofritti; Giulia Daghia; Francesca Cibien; Francesco Cavazzini; Roberto Marasca; Antonio Cuneo
Journal:  Cancer       Date:  2010-04-15       Impact factor: 6.860

8.  Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia.

Authors:  Valter Gattei; Pietro Bulian; Maria Ilaria Del Principe; Antonella Zucchetto; Luca Maurillo; Francesco Buccisano; Riccardo Bomben; Michele Dal-Bo; Fabrizio Luciano; Francesca M Rossi; Massimo Degan; Sergio Amadori; Giovanni Del Poeta
Journal:  Blood       Date:  2007-10-24       Impact factor: 22.113

9.  CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential.

Authors:  Tait D Shanafelt; Susan M Geyer; Nancy D Bone; Renee C Tschumper; Tom E Witzig; Greg S Nowakowski; Clive S Zent; Tim G Call; Betsy Laplant; Gordon W Dewald; Diane F Jelinek; Neil E Kay
Journal:  Br J Haematol       Date:  2008-03       Impact factor: 6.998

10.  The monoclonal anti-VLA-4 antibody natalizumab mobilizes CD34+ hematopoietic progenitor cells in humans.

Authors:  Fabian Zohren; Diamandis Toutzaris; Viola Klärner; Hans-Peter Hartung; Bernd Kieseier; Rainer Haas
Journal:  Blood       Date:  2008-01-30       Impact factor: 22.113
View more
  4 in total

Review 1.  Cancer stem cells in basic science and in translational oncology: can we translate into clinical application?

Authors:  Axel Schulenburg; Katharina Blatt; Sabine Cerny-Reiterer; Irina Sadovnik; Harald Herrmann; Brigitte Marian; Thomas W Grunt; Christoph C Zielinski; Peter Valent
Journal:  J Hematol Oncol       Date:  2015-02-25       Impact factor: 17.388

2.  The SIRT1/TP53 axis is activated upon B-cell receptor triggering via miR-132 up-regulation in chronic lymphocytic leukemia cells.

Authors:  Michele Dal Bo; Tiziana D'Agaro; Stefania Gobessi; Antonella Zucchetto; Sara Dereani; Davide Rossi; Francesco Zaja; Gabriele Pozzato; Francesco Di Raimondo; Gianluca Gaidano; Luca Laurenti; Giovanni Del Poeta; Dimitar G Efremov; Valter Gattei; Riccardo Bomben
Journal:  Oncotarget       Date:  2015-08-07

3.  NOTCH1 Is Aberrantly Activated in Chronic Lymphocytic Leukemia Hematopoietic Stem Cells.

Authors:  Mauro Di Ianni; Stefano Baldoni; Beatrice Del Papa; Patrizia Aureli; Erica Dorillo; Filomena De Falco; Elisa Albi; Emanuela Varasano; Ambra Di Tommaso; Raffaella Giancola; Patrizia Accorsi; Gianluca Rotta; Chiara Rompietti; Estevão Carlos Silva Barcelos; Antonio Francesco Campese; Paolo Di Bartolomeo; Isabella Screpanti; Emanuela Rosati; Franca Falzetti; Paolo Sportoletti
Journal:  Front Oncol       Date:  2018-04-20       Impact factor: 6.244

Review 4.  Multiple Mechanisms of NOTCH1 Activation in Chronic Lymphocytic Leukemia: NOTCH1 Mutations and Beyond.

Authors:  Federico Pozzo; Tamara Bittolo; Erika Tissino; Antonella Zucchetto; Riccardo Bomben; Laura Polcik; Svenja Dannewitz Prosseda; Tanja Nicole Hartmann; Valter Gattei
Journal:  Cancers (Basel)       Date:  2022-06-17       Impact factor: 6.575
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.